Dean Falb

2018

In 2018, Dean Falb earned a total compensation of $1.6M as Chief Scientific Officer at LogicBio Therapeutics.

Compensation breakdown

Bonus$58,186
Option Awards$1,295,815
Salary$205,990
Other$4,120
Total$1,564,111

Falb received $1.3M in option awards, accounting for 83% of the total pay in 2018.

Falb also received $58.2K in bonus, $206K in salary and $4.1K in other compensation.

Rankings

In 2018, Dean Falb's compensation ranked 6,954th out of 14,244 executives tracked by ExecPay. In other words, Falb earned more than 51.2% of executives.

ClassificationRankingPercentile
All
6,954
out of 14,244
51st
Division
Manufacturing
2,669
out of 5,759
54th
Major group
Chemicals And Allied Products
1,005
out of 2,122
53rd
Industry group
Drugs
844
out of 1,811
53rd
Industry
Biological Products, Except Diagnostic Substances
162
out of 339
52nd
Source: SEC filing on April 29, 2019.

Falb's colleagues

We found two more compensation records of executives who worked with Dean Falb at LogicBio Therapeutics in 2018.

2018

Sandra Poole

LogicBio Therapeutics

Chief Operating Officer

2018

Frederic Chereau

LogicBio Therapeutics

Chief Executive Officer

News

In-depth

You may also like